Intimation of participation in the Investor Conferences
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has informed the stock exchanges that its officials will participate in two investor conferences being held in London. The first is the India Corporate Day organized by Kotak on June 23, 2025, and the second is the IIFL 9th Invest India Conference from June 24 to June 25, 2025. Both events will include one-on-one and group meetings with investors. The company has clarified that no unpublished price-sensitive information will be shared at these conferences. The schedule may change due to unforeseen circumstances. This is a routine regulatory disclosure under SEBI's listing rules.
This is a routine investor outreach activity with no new business or financial information being disclosed, so it is largely neutral for the stock. It may, however, give institutional investors a chance to engage with management, which can support sentiment.